YF-VAX (yellow fever vaccine live/PF)
YELLOW FEVER VACCINE · YELLOW FEVER VACCINATION
SANOFI-PASTEUR
Drug class
Yellow Fever Vaccine
The yellow fever vaccine class encompasses live-attenuated viral vaccines specifically formulated using attenuated strains of the yellow fever virus, such as 17D-204. Read more about Yellow Fever Vaccine
4 drugs in this class 1 manufacturers
Drugs in Yellow Fever Vaccine
STAMARIL (yellow fever vaccine live/PF)
YELLOW FEVER VACCINE · YELLOW FEVER VACCINATION
SANOFI-PASTEUR
YF-VAX (PF) (yellow fever vaccine live/PF)
YELLOW FEVER VACCINE · YELLOW FEVER VACCINATION
SANOFI-PASTEUR
STAMARIL (PF) (yellow fever vaccine live/PF)
YELLOW FEVER VACCINE · YELLOW FEVER VACCINATION
SANOFI-PASTEUR
Filter & compare in the drug finder →
Opens the drug finder with Yellow Fever Vaccine preselected. Add indication or manufacturer filters there.
The yellow fever vaccine class encompasses live-attenuated viral vaccines specifically formulated using attenuated strains of the yellow fever virus, such as 17D-204.
Functioning as an active immunizing agent, the vaccine stimulates the host immune system to elicit neutralizing antibodies and robust cell-mediated immunity against the yellow fever flavivirus.
Therapeutics within this class are indicated exclusively for the prevention of yellow fever disease in individuals residing in or traveling to endemic regions of Sub-Saharan Africa and tropical South America, as well as laboratory personnel with potential viral exposure.
-
fda.gov
The yellow fever vaccine class encompasses live-attenuated viral vaccines specifically formulated using attenuated strains of the yellow fever virus, such as 17D-204
-
drugs.com
The yellow fever vaccine class encompasses live-attenuated viral vaccines specifically formulated using attenuated strains of the yellow fever virus, such as 17D-204
-
fda.gov
Functioning as an active immunizing agent, the vaccine stimulates the host immune system to elicit neutralizing antibodies and robust cell-mediated immunity against the yellow fever flavivirus Therapeutics within this class are indicated exclusively for the prevention of yellow fever disease in individuals residing in or traveling to endemic regions of Sub-Saharan Africa and tropical South America, as well as laboratory personnel with potential viral exposure
-
nih.gov
Functioning as an active immunizing agent, the vaccine stimulates the host immune system to elicit neutralizing antibodies and robust cell-mediated immunity against the yellow fever flavivirus
-
medlineplus.gov
Functioning as an active immunizing agent, the vaccine stimulates the host immune system to elicit neutralizing antibodies and robust cell-mediated immunity against the yellow fever flavivirus
-
cdc.gov
Therapeutics within this class are indicated exclusively for the prevention of yellow fever disease in individuals residing in or traveling to endemic regions of Sub-Saharan Africa and tropical South America, as well as laboratory personnel with potential viral exposure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.